MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE

Compare MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE (EMROSI) and TETRACYCLINE HYDROCHLORIDE (Tetracycline Hydrochloride) — clinical data, side effects, and patient experiences.

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

EMROSI · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action The mechanism of action of EMROSI for the treatment of rosacea is unknown.

Approved for

use EMROSI only as indicated. ( 1 )

OralTablet

TETRACYCLINE HYDROCHLORIDE

Tetracycline Hydrochloride · Tetracycline Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

Streptococcus pneumoniae

Mycoplasma pneumoniae (Eaton agent

OralTablet

Quick Comparison

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASETETRACYCLINE HYDROCHLORIDE

Drug Class

Tetracycline Antibiotic

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

Drug Not Working

>10%

Nausea

1-10%

Joint Pain

1-10%

Fatigue

1-10%

Rash

1-10%

Headache

1-10%

Condition Worsened

1-10%

Diarrhea

0.1-1%

TETRACYCLINE HYDROCHLORIDE

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

Joint Pain

1-10%

Fatigue

1-10%

FDA Warnings

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

5 WARNINGS AND PRECAUTIONS Serious Skin/Hypersensitivity Reactions: Minocycline has been associated with anaphylaxis, serious skin reactions, erythema multiforme, and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome
1 Hypersensitivity Reaction and Serious Skin Reactions Cases of anaphylaxis, serious skin reactions (e
In some cases, death has been reported
Advise the patient of the potential risk to the fetus if EMROSI is used during the second or third trimester of pregnancy [see Use in Specific Populations (8

TETRACYCLINE HYDROCHLORIDE

WARNINGS Tooth Development The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated
Clostridium difficile Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including tetracyclines, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

Clinical Trial Data

No head-to-head clinical studies found for MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE.

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE: What You Should Know

Key Differences

Both MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE and TETRACYCLINE HYDROCHLORIDE belong to the Tetracycline Antibiotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE carries 4 FDA warnings. TETRACYCLINE HYDROCHLORIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DOXYCYCLINE MONOHYDRATE vs TETRACYCLINE HYDROCHLORIDE→DOXYCYCLINE MONOHYDRATE vs MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE→TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE→MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TIGECYCLINE→OMADACYCLINE vs TETRACYCLINE HYDROCHLORIDE→MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs OMADACYCLINE→

Loading comparison data...

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE

Compare MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE (EMROSI) and TETRACYCLINE HYDROCHLORIDE (Tetracycline Hydrochloride) — clinical data, side effects, and patient experiences.

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

EMROSI · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action The mechanism of action of EMROSI for the treatment of rosacea is unknown.

Approved for

use EMROSI only as indicated. ( 1 )

OralTablet

TETRACYCLINE HYDROCHLORIDE

Tetracycline Hydrochloride · Tetracycline Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

Streptococcus pneumoniae

Mycoplasma pneumoniae (Eaton agent

OralTablet

Quick Comparison

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASETETRACYCLINE HYDROCHLORIDE

Drug Class

Tetracycline Antibiotic

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

Drug Not Working

>10%

Nausea

1-10%

Joint Pain

1-10%

Fatigue

1-10%

Rash

1-10%

Headache

1-10%

Condition Worsened

1-10%

Diarrhea

0.1-1%

TETRACYCLINE HYDROCHLORIDE

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

Joint Pain

1-10%

Fatigue

1-10%

FDA Warnings

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE

5 WARNINGS AND PRECAUTIONS Serious Skin/Hypersensitivity Reactions: Minocycline has been associated with anaphylaxis, serious skin reactions, erythema multiforme, and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome
1 Hypersensitivity Reaction and Serious Skin Reactions Cases of anaphylaxis, serious skin reactions (e
In some cases, death has been reported
Advise the patient of the potential risk to the fetus if EMROSI is used during the second or third trimester of pregnancy [see Use in Specific Populations (8

TETRACYCLINE HYDROCHLORIDE

WARNINGS Tooth Development The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated
Clostridium difficile Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including tetracyclines, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

Clinical Trial Data

No head-to-head clinical studies found for MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE.

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE vs TETRACYCLINE HYDROCHLORIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.